Learning Objectives: -Apply recent national guidelines to guide individualized treatment selection for various blood cancers, focusing on the integration of the latest clinical safety and efficacy data. -Differentiate between the advantages and disadvantages of various treatment modalities, including frontline and second-line treatments, CAR T and bispecific therapies, JAK inhibitors, and TKIs, considering individual patient characteristics and needs. -Optimize patient assessment by incorporating genetic, biomarker testing, frailty assessments, and consideration of individual characteristics, to ensure effective, individualized patient care.
- Provider:Medical Learning Institute, Inc.
- Activity Link: https://learn.mlieducation.org/courses/7d93dbc0-7770-11ef-8d13-4f1b94e3e890
- Start Date: 2024-10-07 05:00:00
- End Date: 2024-10-07 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.25 hours
AMA PRA Category 1 Credit™️: 1.25 hours
Nursing: 1.25 hours
Pharmacy: 1.25 hours - MOC Credit Details: ABIM - 1.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Hematology, Internal Medicine, Medical Oncology
Subscribe
Login
0 Comments
Oldest